Colgate-Palmolive Company Company Profile (NYSE:CL)

Colgate-Palmolive Company trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Colgate-Palmolive Company announced a quarterly dividend on Thursday, June 8th. Investors of record on Tuesday, July 18th will be paid a dividend of $0.40 per share on Tuesday, August 15th. This represents a $1.60 annualized dividend and a yield of 2.21%. The ex-dividend date is Friday, July 14th. View Colgate-Palmolive Company's Dividend History.

Colgate-Palmolive Company (NYSE:CL) issued its quarterly earnings results on Friday, July, 21st. The company reported $0.72 earnings per share for the quarter, meeting the Zacks' consensus estimate of $0.72. The firm earned $3.83 billion during the quarter, compared to the consensus estimate of $3.89 billion. Colgate-Palmolive Company had a net margin of 15.83% and a return on equity of 3,121.95%. The firm's revenue was down .5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.70 EPS. View Colgate-Palmolive Company's Earnings History.

Colgate-Palmolive Company is scheduled to release their next quarterly earnings announcement on Friday, October, 27th 2017. View Earnings Estimates for Colgate-Palmolive Company.

13 brokers have issued 1 year price objectives for Colgate-Palmolive Company's shares. Their forecasts range from $68.00 to $80.00. On average, they expect Colgate-Palmolive Company's stock price to reach $74.91 in the next year. View Analyst Ratings for Colgate-Palmolive Company.

Here are some recent quotes from research analysts about Colgate-Palmolive Company stock:

• 1. According to Zacks Investment Research, "Colgate, which has underperformed the industry in the past three months, has a dismal sales surprise history. Evidently, the company has lagged sales estimates in 16 out of the trailing 17 quarters. Well, Colgate marked its fifth straight sales miss in the last reported quarter, mainly due to continued softness in North America and challenges in Asia-Pacific. Furthermore, low global unit volumes and adverse currency fluctuations were deterrents. Going forward, the company anticipates the backdrop to remain challenging due to uncertain global markets and slowing category growth worldwide. Consequently, the company lowered its organic sales growth and GAAP earnings guidance for 2017. Nevertheless, we commend Colgate’s progress on its 2012 Restructuring Program. Notably, management expects additional opportunities identified under the program to help reach the higher end of its previously stated cost and savings forecast." (9/20/2017)
• 2. Jefferies Group LLC analysts commented, "Late Tues. (5/16), the NY Post reported that CL Chair/CEO Ian Cook recently told investors he would consider selling the company for $100/share (~19.5x EV/EBITDA). While we have no knowledge of any potential M&A or the specific accuracy of this report, this strikes us as a reasonable price (for both a potential buyer and for CL as sellers). We view JNJ as the most likely acquirer, followed by ULVR and KHC/3G. Valuation remains nearly full, reit. $76 PT, Hold. CL CEO/Chairman Ian Cook reportedly would consider selling for $100/share: Late Tuesday, the NY Post reported the Ian Cook, Colgate’s Chairman and CEO, recently signaled he would be open to selling the company… for $100/share", while at a meeting with institutional investors. The Post further noted recent speculation the CL is being stalked by" Unilever and pointed to activist Nelson Peltz’s stake in P&G as a potential spark for sector consolidation." (5/17/2017)

Colgate-Palmolive Company saw a drop in short interest during the month of August. As of August 31st, there was short interest totalling 4,803,434 shares, a drop of 36.6% from the August 15th total of 7,575,369 shares. Based on an average daily trading volume, of 2,703,602 shares, the days-to-cover ratio is presently 1.8 days. Currently, 0.5% of the shares of the company are sold short.

Some companies that are related to Colgate-Palmolive Company include Unilever plc (ULVR), Estee Lauder Companies, Inc. (The) (EL), Herbalife LTD. (HLF), Energizer Holdings (EPC), Nu Skin Enterprises (NUS), Matthews International Corporation (MATW), USANA Health Sciences (USNA), PZ Cussons plc (PZC), Avon Products (AVP), Revlon (REV), Nautilus Group, Inc. (The) (NLS), KP Tissue (KPT), Swallowfield plc (SWL), Blackmores Limited (BKL), DS Healthcare Group (DSKX), L'Oreal SA (OR) and Litebulb Group Ltd (LBB).

Colgate-Palmolive Company's management team includes the folowing people:

• Ian M. Cook, Chairman of the Board, President, Chief Executive Officer
• Daniel B. Marsili, Chief Human Resource Officer
• John J. Huston, Senior Vice President - Chief of Staff
• Patricia Verduin Ph.D., Chief Technology Officer
• Mukul V. Deoras, Chief Marketing Officer
• Victoria L. Dolan, Chief Transformation Officer, Corporate Controller
• Delia H. Thompson, Chief Investor Relations Officer
• Makarand Karnataki, Company Secretary and Compliance Officer
• Jennifer M. Daniels, Chief Legal Officer and Secretary
• Charles A. Bancroft, Independent Director

Colgate-Palmolive Company's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.71%), State Street Corp (6.67%), BlackRock Inc. (5.77%), FMR LLC (3.18%), Bank of New York Mellon Corp (2.05%) and Northern Trust Corp (1.20%). Company insiders that own Colgate-Palmolive Company stock include Daniel B Marsili, Delano E Lewis, Delia H Thompson, Dennis J Hickey, Ellen M Hancock, Fabian T Garcia, Franck J Moison, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive Company.

Colgate-Palmolive Company's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Sustainable Growth Advisers LP, State Street Corp, Capital World Investors, Ameriprise Financial Inc., Bank of New York Mellon Corp, BlackRock Inc. and Aviva PLC. Company insiders that have sold Colgate-Palmolive Company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Patricia Verduin, Richard J Kogan and Stephen I Sadove. View Insider Buying and Selling for Colgate-Palmolive Company.

Colgate-Palmolive Company's stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Vanguard Group Inc., Arrowstreet Capital Limited Partnership, Parametric Portfolio Associates LLC, Fiera Capital Corp, HAP Trading LLC, Principal Financial Group Inc. and MARSHALL WACE ASIA Ltd. View Insider Buying and Selling for Colgate-Palmolive Company.

Shares of Colgate-Palmolive Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Colgate-Palmolive Company stock can currently be purchased for approximately $72.55.